MDNews - Lower Hudson/Bronx

November 2013

Issue link: https://viewer.e-digitaledition.com/i/205083

Contents of this Issue

Navigation

Page 20 of 35

less-invasive treatment modality could be as transformational for medicine as the discovery of penicillin. A Neighborhood Resource Although the idea has been around for the better half of 50 years, we only now have the technology to reach a more complete understanding of what the gut microbiota means to human health and well-being. Physicians and researchers stand on the precipice of discovery, and Drs. Brandt and Wolkoff are among those advancing into this brave new world. Montefiore Medical Center is one of three institutions — and the only medical center — conducting clinical trials to study this innovative, lifesaving therapy. "This is an exciting time because we're making real breakthroughs," Dr. Wolkoff says. "It's similar to when we discovered that a form of bacterium — H. pylori — is responsible for stomach ulcers. We now know that bacteria can be associated with major gastrointestinal problems. In Montefiore Medical Center, physicians in our community have a resource where specialists are happy to work with them to benefit their patients." For more inf or mat ion about Montef iore Medical Center's leading-edge t reat ments and research, visit www.montefiore.org/gastroenterology. ■ speCial CliniCal seCtion: GASTRoeNTeRoloGY Identifying specific bacteria for these capsules is the foremost priority for microbiota study on the national level, and as bacterial relationships are identified and disease processes are linked to specific microbes, the number of diseases treated with bacterial therapy will multiply exponentially. "There's no question in my mind that in five years, we'll have developed stool-derived products," Dr. Brandt says. "These may be multiple species or metabolic products of bacteria, or a combination of the two. I think it's conceivable that there will be a menu of different bacteria and combinations of bacteria as therapies for different diseases." Obesity could be the next breakthrough application for bacterial therapy. In another project in its infancy at Montefiore Medical Center, researchers are studying this possibility. "The dream would be that an obese person could take a pill with bacteria provided by a person with a healthy weight, and the obese person would become thin," Dr. Wolkoff explains. "This is purely speculative at this point, but one needs to dream and test hypotheses to make important advances." Bariatric surgeons at Montefiore perform an estimated 700 gastric bypass procedures annually, notes Dr. Wolkoff. As obesity continues to plague America, an effective, Case consultation with Drs. Brandt and Wolkoff MDNeWS.CoM ■ MD News Lower Hudson/Bronx | 21

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - November 2013